Published in Am J Ophthalmol on August 16, 2008
Randomized comparison of systemic anti-inflammatory therapy versus fluocinolone acetonide implant for intermediate, posterior, and panuveitis: the multicenter uveitis steroid treatment trial. Ophthalmology (2011) 2.00
The multicenter uveitis steroid treatment trial: rationale, design, and baseline characteristics. Am J Ophthalmol (2010) 1.83
Incidence rates and risk factors for ocular complications and vision loss in HLA-B27-associated uveitis. Am J Ophthalmol (2010) 1.15
Hypotony in patients with uveitis: The Multicenter Uveitis Steroid Treatment (MUST) Trial. Ocul Immunol Inflamm (2012) 1.02
Behçet's Uveitis. Middle East Afr J Ophthalmol (2009) 1.02
Incidence of visual improvement in uveitis cases with visual impairment caused by macular edema. Ophthalmology (2013) 0.91
Ischemic retinal vasculitis and its management. J Ophthalmol (2014) 0.86
Success with single-agent immunosuppression for multifocal choroidopathies. Am J Ophthalmol (2014) 0.86
Evaluation of current therapeutic strategies in Behçet's disease. Clin Rheumatol (2010) 0.82
Best-corrected visual acuity and frequency of ocular attacks during the initial 10 years in patients with Behçet's disease. Graefes Arch Clin Exp Ophthalmol (2009) 0.79
Risk of relapse in primary acute anterior uveitis. Ophthalmology (2011) 0.78
Efficacy of infliximab in refractory Behçet's disease-associated and idiopathic posterior segment uveitis: a prospective, follow-up study of 50 patients. Biologics (2011) 0.77
Behçet's disease leaves the silk road. Postepy Dermatol Alergol (2014) 0.77
Correlation between Fluorescein Angiographic Findings and Visual Acuity in Behçet Retinal Vasculitis. Yonsei Med J (2015) 0.75
Severe panuveitis in neuro-Behçet's disease in Malaysia: a case series. Int Med Case Rep J (2017) 0.75
Clinical trials in noninfectious uveitis. Int Ophthalmol Clin (2015) 0.75
The Effectiveness of Intraocular Methotrexate in the Treatment of Posterior Uveitis in Behçet's Disease Patients Compared to Retrobulbar Steroids Injection. J Ophthalmol (2016) 0.75
Morbus Behçet - a rare disease in Central Europe. Arch Med Sci (2015) 0.75
Pattern and causes of visual loss in Behçet's uveitis: short-term and long-term outcomes. Graefes Arch Clin Exp Ophthalmol (2017) 0.75
The Effectiveness of Pre- and Postoperative Infliximab in Controlling Behçet's Disease Posterior Uveitis in Patients Undergoing Vitrectomy: A Preliminary Study. J Ophthalmol (2017) 0.75
Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease. Lancet (1990) 19.57
Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol (2005) 13.50
A controlled trial of azathioprine in Behçet's syndrome. N Engl J Med (1990) 2.77
Current concepts in the etiology and treatment of Behçet disease. Surv Ophthalmol (2005) 2.48
Uveitis in Behçet disease: an analysis of 880 patients. Am J Ophthalmol (2004) 2.09
Double-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in Behçet's disease. Lancet (1989) 1.92
Methods for identifying long-term adverse effects of treatment in patients with eye diseases: the Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study. Ophthalmic Epidemiol (2008) 1.87
Prognostic factors of vision in patients with Behçet disease. Ophthalmology (1995) 1.75
The rate of visual loss in Behçet's disease. Arch Ophthalmol (1970) 1.51
The use of interferon alpha in Behçet disease: review of the literature. Semin Arthritis Rheum (2004) 1.44
Ocular features of Behcet's disease: an international collaborative study. Br J Ophthalmol (2007) 1.35
Behçet's disease: from Hippocrates to the third millennium. Br J Ophthalmol (2003) 1.30
Behçet's disease. Surv Ophthalmol (1982) 1.28
Risk of vision loss in patients with cytomegalovirus retinitis and the acquired immunodeficiency syndrome. Arch Ophthalmol (2003) 1.18
Comparison of patients with Behçet's disease in the 1980s and 1990s. Ophthalmology (2004) 1.16
Epidemiology and clinical course of Behçet's disease in the Reggio Emilia area of Northern Italy: a seventeen-year population-based study. Arthritis Rheum (2007) 1.07
Risk and prognostic factors of poor visual outcome in Behcet's disease with ocular involvement. Graefes Arch Clin Exp Ophthalmol (2005) 1.07
Behçet's disease in Japan and in Great Britain: a comparative study. Ocul Immunol Inflamm (2000) 1.05
Risk factor assessment and prognosis of eye involvement in Behcet's disease in Turkey. Ophthalmology (1997) 1.05
Immunopathology of the noninfectious posterior and intermediate uveitides. Surv Ophthalmol (2001) 1.02
Behçet's disease: global epidemiology of an Old Silk Road disease. Br J Ophthalmol (2007) 0.95
Prevalence and clinical aspects of Behcet's disease in the north of Israel. Clin Rheumatol (2006) 0.95
Infliximab treatment for ocular and extraocular manifestations of Behçet's disease. Jpn J Ophthalmol (2007) 0.92
Adamantiades-Behcet disease: diagnosis and current concepts in management of ocular manifestations. Compr Ophthalmol Update (2007) 0.89
Long-term infliximab treatment for Behçet's disease. Jpn J Ophthalmol (2007) 0.84
Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol (2005) 13.50
Effects of medical therapies on retinopathy progression in type 2 diabetes. N Engl J Med (2010) 10.75
TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1. Nat Med (2007) 5.41
Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis. Sci Transl Med (2010) 4.95
Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis. Arch Ophthalmol (2011) 3.63
A prospective trial of infliximab therapy for refractory uveitis: preliminary safety and efficacy outcomes. Arch Ophthalmol (2005) 3.50
Childhood uveitis-young patients, old problems, new perspectives. J AAPOS (2008) 3.12
Do tumor necrosis factor inhibitors cause uveitis? A registry-based study. Arthritis Rheum (2007) 3.11
Cutting edge: NKT cells constitutively express IL-23 receptor and RORgammat and rapidly produce IL-17 upon receptor ligation in an IL-6-independent fashion. J Immunol (2008) 2.90
Nonsteroidal anti-inflammatory drugs for the prevention of Alzheimer's disease: a systematic review. Neuroepidemiology (2004) 2.63
Toxoplasma gondii in the peripheral blood of patients with acute and chronic toxoplasmosis. Br J Ophthalmol (2010) 2.50
Surgical strategies for coexisting glaucoma and cataract: an evidence-based update. Ophthalmology (2002) 2.45
Fundus autofluorescence imaging of the white dot syndromes. Arch Ophthalmol (2010) 2.26
Overall and cancer related mortality among patients with ocular inflammation treated with immunosuppressive drugs: retrospective cohort study. BMJ (2009) 2.23
Evaluation of patients with scleritis for systemic disease. Ophthalmology (2004) 2.22
Baseline predictors for one-year visual outcomes with ranibizumab or bevacizumab for neovascular age-related macular degeneration. Ophthalmology (2012) 2.19
U.S. trends in antiretroviral therapy use, HIV RNA plasma viral loads, and CD4 T-lymphocyte cell counts among HIV-infected persons, 2000 to 2008. Ann Intern Med (2012) 2.18
Plasmapheresis for lupus retinal vasculitis. Arch Ophthalmol (2006) 2.13
The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators. Arch Dermatol (2002) 2.10
Effective tumor treatment targeting a melanoma/melanocyte-associated antigen triggers severe ocular autoimmunity. Proc Natl Acad Sci U S A (2008) 2.07
NOD2 transgenic mice exhibit enhanced MDP-mediated down-regulation of TLR2 responses and resistance to colitis induction. Gastroenterology (2007) 2.03
Uveitis in patients with autoimmune hepatitis. Am J Ophthalmol (2009) 2.02
Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature. Ann Allergy Asthma Immunol (2005) 2.01
Randomized comparison of systemic anti-inflammatory therapy versus fluocinolone acetonide implant for intermediate, posterior, and panuveitis: the multicenter uveitis steroid treatment trial. Ophthalmology (2011) 2.00
Intraocular lymphoma. Curr Opin Ophthalmol (2002) 1.96
Trends and disparities in antiretroviral therapy initiation and virologic suppression among newly treatment-eligible HIV-infected individuals in North America, 2001-2009. Clin Infect Dis (2013) 1.94
Methods for identifying long-term adverse effects of treatment in patients with eye diseases: the Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study. Ophthalmic Epidemiol (2008) 1.87
The NOD2 defect in Blau syndrome does not result in excess interleukin-1 activity. Arthritis Rheum (2009) 1.87
Clinical characteristics of a large cohort of patients with scleritis and episcleritis. Ophthalmology (2011) 1.85
Identification of a susceptibility locus in STAT4 for Behçet's disease in Han Chinese in a genome-wide association study. Arthritis Rheum (2012) 1.84
Cardiovascular events and death in children exposed and unexposed to ADHD agents. Pediatrics (2011) 1.84
The need for standardization of antiretinal antibody detection and measurement. Am J Ophthalmol (2008) 1.83
The multicenter uveitis steroid treatment trial: rationale, design, and baseline characteristics. Am J Ophthalmol (2010) 1.83
Immunosuppressant medications and mortality in inflammatory bowel disease. Am J Gastroenterol (2008) 1.80
Validation of diagnostic codes for outpatient-originating sudden cardiac death and ventricular arrhythmia in Medicaid and Medicare claims data. Pharmacoepidemiol Drug Saf (2010) 1.78
Ocular and systemic autoimmunity after successful tumor-infiltrating lymphocyte immunotherapy for recurrent, metastatic melanoma. Ophthalmology (2009) 1.78
Cyclosporine for ocular inflammatory diseases. Ophthalmology (2010) 1.75
The impact of anemia on energy and physical functioning in individuals with AIDS. Arch Intern Med (2005) 1.75
Sympathetic ophthalmia: what have we learned? Am J Ophthalmol (2009) 1.73
Photographic assessment of baseline fundus morphologic features in the Comparison of Age-Related Macular Degeneration Treatments Trials. Ophthalmology (2012) 1.70
Infliximab therapy for refractory uveitis: 2-year results of a prospective trial. Arch Ophthalmol (2009) 1.69
Analysis of pediatric uveitis cases at a tertiary referral center. Ophthalmology (2005) 1.69
Evaluation of patients with dry eye for presence of underlying Sjögren syndrome. Cornea (2009) 1.69
Longitudinal study of the ocular complications of AIDS: 1. Ocular diagnoses at enrollment. Ophthalmology (2007) 1.68
Relapsing polychondritis: a clinical review. Semin Arthritis Rheum (2002) 1.68
Quality of Medicaid and Medicare data obtained through Centers for Medicare and Medicaid Services (CMS). Med Care (2007) 1.66
Juvenile idiopathic arthritis-associated uveitis: incidence of ocular complications and visual acuity loss. Am J Ophthalmol (2007) 1.66
Intravitreal bevacizumab for treatment of uveitic macular edema. Ophthalmology (2007) 1.66
Humanized anti-interleukin-2 (IL-2) receptor alpha therapy: long-term results in uveitis patients and preliminary safety and activity data for establishing parameters for subcutaneous administration. J Autoimmun (2003) 1.66
Gene expression profiling of whole blood: comparison of target preparation methods for accurate and reproducible microarray analysis. BMC Genomics (2009) 1.64
Antidepressants and the risk of sudden cardiac death and ventricular arrhythmia. Pharmacoepidemiol Drug Saf (2011) 1.63
Nonsteroidal anti-inflammatory therapy and recurrent acute anterior uveitis. Ocul Immunol Inflamm (2010) 1.62
Adverse effects of smoking on patients with ocular inflammation. Br J Ophthalmol (2010) 1.61
Methotrexate for ocular inflammatory diseases. Ophthalmology (2009) 1.58